Want to join the conversation?
$PFE announced positive top-line results from the Phase 3 PALOMA-2 trial for IBRANCE (palbociclib), oral, first-in-class inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. The study met primary endpoint by demonstrating improvement in progression-free survival (PFS).
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.